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apy were given. Before starting chemotherapy serum tumor markers
were all within normal range except for AFP: 532 ng/mL (normal
valueb9 ng/mL)which fellwithin the normal range after three courses
of chemotherapy. A routine CT scan, after chemotherapy documented
the disappearance of pelvic disease and the appearance of four hetero-
geneous liver mass of 5 cm diameter, with cystic, solid and calciﬁc
components so patient underwent surgical excision of liver masses.
The histology showed the presence of mature cystic teratomawithout
malignant elements and the ﬁnal diagnosis was GTS.Introduction
The growing teratoma syndrome (GTS) is a rare situation in
which enlarging masses with benign histology are detected during
or after chemotherapy treatment for a malignant germ cell tumor
(MGCT). In 1993 Kattan et al. described the case of a woman with GTS
in which peritoneal nodules secondary inﬁltrating the liver paren-
chyma and causing small bowel necrosis and urinary tract obstruction
appeared during chemotherapy treatment for MGCT. We describe
the ﬁrst two reported cases of GTS with liver locations occurring after
fertility sparing surgery and chemotherapy in two ovarian MGCTs
(Tewari et al., 2000; Geisler et al., 1994; DiSaia et al., 1977; Itani et al.,
2002).Case report
First case
A33-year-oldwomanpresentedwith increased abdominal volume
and pelvic pain. CT scan documented a 114×96×99 mm heteroge-
neous mass arising from the right ovary. The patient underwent an
initial fertility-sparing surgery and histology revealed a FIGO stage
IIB mixed MGCT constituted by three different components: yolk sac
tumor (80%), immature teratoma (10%), and dysgerminoma (10%).c Oncology, Catholic University
Rome, Italy. Fax: +39 06 3550
s under CC BY-NC-ND license.Second case
In December 2009 a 19-year-old woman presented with pelvic
pain and weight loss. MRI scan detected two enlarged complex mass
in the left ovary. The patient underwent an initial fertility-sparing
surgery and histology revealed the presence of a FIGO stage IA G3
immature teratoma. According to our internal protocol patient did not
received adjuvant chemotherapy because of the low risk of recurrent
disease and the quite complete possibility of rescue when chemo-
therapy is given at recurrence. In August 2010 a CT scan revealed the
presence of a 6.5 cm complex mass in left ovarian region and serum
tumor marker increase (AFP 105 ng/mL). Patient underwent surgical
removal of themass and partial peritonectomy of bladder and Douglas
cavity. Histology conﬁrmed the diagnosis of immature teratoma so
patient received four courses of BEP chemotherapy. After surgery all
serum tumor markers were negative except for AFP: 64 ng/mL
(normal value after two courses of chemotherapy). After chemother-
apy a CT scan documented the appearance of two heterogeneous liver
mass of about 5 cm diameter, with solid and calciﬁc components so
patient underwent a surgical excision of liver masses. The histological
report showed the presence of mature cystic teratoma without ma-
lignant elements.
No further chemotherapy was administered and at a median
follow up of 6 months both patients are disease free.Discussion
GTS is an uncommon entity characterized by recurrence of mature
teratoma lesions in extratesticular sites after orchiectomy of primary
non seminomatous germ cell tumor in young men (incidence 1.9–
7.9%). Only 15 cases have been reported in women. Involved sites
are in most cases locations previously affected by the disease, mainly
25D. Lorusso et al. / Gynecologic Oncology Reports 1 (2011) 24–25retroperitoneum (80%) and chest, but have also been described at
mediastinum and cervical lymph nodes. We describe the ﬁrst two
cases of liver locations of GTS in women. The presence of mature
teratoma elements in the primary tumor, the incomplete primary
tumor resection and the absence of volume mass reduction during
chemotherapy have been identiﬁed the factors most likely predicting
the development of GTS (DiSaia et al., 1977). DiSaia et al. (1977) were
the ﬁrst to describe this phenomenon as “chemotherapeutic retro-
conversion.” Logothetis et al. (Itani et al., 2002) observed similar
clinical progression in males with germ cell tumor of testis and coined
the term“growing teratoma syndrome.” Aronowitz et al. (DiSaia et al.,
1977) describe this phenomenon in women. GTS is characterized by
normalization of previously elevated tumor markers (AFP or beta-
HCG), enlargement of pre-existing tumor or appearance of a new
tumor mass, and only mature teratoma elements in pathologic
examination. The radiological features may include increased density
of mass with well circumscribed margins, onset of internal calciﬁca-
tion with fatty areas and cystic change (Geisler et al., 1994) although
no radiological or ultrasound ﬁndings have been described which
can help in distinguish between malignant and mature tissue. The
possible pathogenesis of GTS development is either a malignant cell
differentiation into mature teratoma or a selective chemotherapy
induced destruction of immature elements. Complete surgical ex-
cision is required to avoid compressive effects (Itani et al., 2002),
the risk of rupturing, displacement of adjacent organs and potentialmalignant transformation into either sarcoma or carcinoma which
is reported in 3% of cases. The prognosis is excellent and only few
cases of deaths are reported in literature. The risk of recurrence is
related to the rate of complete surgical resection, being described
in 22% vs 11% of incompletely and completely resected patients
respectively. The growth or persistence of a tumor mass after che-
motherapy for MGCTs does not necessarily imply progression of
malignancy, especially if tumor markers are normal. Radiologically
it is difﬁcult to distinguish GTS from recurrent MGCT. If recurrence or
persistence of malignancy is conﬁrmed, further chemotherapy treat-
ment should be given.
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